GlassScriptPhysician profile
Christopher M Merrick
NPI 1942566419
$33,631.04
in general payments reported to CMS, 2019-2025
41 companies · $30K in 2025
The $30K reported for 2025 was more than what 96% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $676 · 2020: $711 · 2021: $415 · 2022: $594 · 2023: $778 · 2024: $698 · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Food and Beverage: $14K · Travel and Lodging: $3,321 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,120.00 |
| Food and Beverage | $13,694.19 |
| Travel and Lodging | $3,321.26 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $13,438.98 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Electromed, INC. | $10,608.93 | 2024-2025 | Smartvest |
| Genzyme Corporation | $2,797.46 | 2022-2025 | |
| Insmed, INC. | $1,787.11 | 2019-2025 | Arikayce, Brinsupri |
| Astrazeneca Pharmaceuticals LP | $1,386.13 | 2019-2025 | Tezspire, Breztri, Fasenra |
| Inari Medical, INC. | $707.64 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Glaxosmithkline, LLC. | $567.21 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Actelion Pharmaceuticals US, INC. | $298.91 | 2019-2025 | Opsumit, Uptravi |
| Grifols USA, LLC | $284.11 | 2019-2025 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $156.68 | 2019-2025 | Dupixent |
| United Therapeutics Corporation | $140.06 | 2019-2025 | Tyvaso, Tyvaso |
| Mylan Specialty L.P. | $138.40 | 2019-2024 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $137.46 | 2020-2025 | Glassia |
| Jazz Pharmaceuticals INC. | $135.37 | 2020-2023 | Xywav |
| Philips North America LLC | $116.10 | 2019-2025 | Vest Therapy Und |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Merrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.